Related Experiment Video
Updated: Aug 7, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation
Monica Kong1, Ching S Wang, Daniel J Donoghue
1Department of Chemistry and Biochemistry, Center for Molecular Genetics, University of California San Diego, La Jolla, California 92093-0367, USA.
Abstract:
Fibroblast growth factor receptor 3 (FGFR3) influences a diverse array of biological processes, including cell growth, differentiation, and migration. Activating mutations in FGFR3 are associated with multiple myeloma, cervical carcinoma, and bladder cancer. To identify proteins that interact with FGFR3 and which may mediate FGFR3-dependent signaling, a yeast two-hybrid screen was employed using the cytoplasmic kinase domain of FGFR3 as bait. We identified the adapter protein SH2-B as an FGFR3-interacting protein. Coimmunoprecipitation experiments demonstrate binding of the SH2-B beta isoform to FGFR3 in 293T cells. Tyrosine phosphorylation of SH2-B beta was observed when coexpressed with activated FGFR3 mutants such as the weakly activated mutant N540K or the strongly activated mutant K650E, both associated with human developmental syndromes. The extent of tyrosine phosphorylation of SH2-B beta correlates with receptor activation, suggesting that FGFR3 activation mediates tyrosine phosphorylation of SH2-B beta. Furthermore, two tyrosine phosphorylation sites of FGFR3, Tyr-724 and Tyr-760, are required for optimal binding of the Src homology-2 (SH2) domain of SH2-B beta. We also demonstrate the phosphorylation and nuclear translocation of Stat5 by activated FGFR3, which increases in response to overexpression of SH2-B beta. Taken together, our results identify SH2-B beta as a novel FGFR3 binding partner that mediates signal transduction.
Insights
Fibroblast growth factor receptor 3 (FGFR3) interacts with SH2-B beta, a novel adapter protein. This interaction mediates FGFR3 signaling, impacting cell growth and cancer development.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Fibroblast growth factor receptor 3 (FGFR3) is crucial for cell growth, differentiation, and migration.
- Activating mutations in FGFR3 are linked to various cancers, including multiple myeloma and bladder cancer.
Purpose of the Study:
- To identify proteins interacting with FGFR3 that may mediate its signaling pathways.
- To elucidate the role of SH2-B beta in FGFR3-dependent signal transduction.
Main Methods:
- Yeast two-hybrid screen using the FGFR3 kinase domain.
- Coimmunoprecipitation assays in 293T cells.
- Analysis of tyrosine phosphorylation sites and Stat5 activation.
Main Results:
- SH2-B beta was identified as an FGFR3-interacting protein.
- FGFR3 activation leads to tyrosine phosphorylation of SH2-B beta, dependent on specific FGFR3 tyrosine residues (Tyr-724 and Tyr-760).
- Activated FGFR3 phosphorylates and translocates Stat5, with increased Stat5 activity upon SH2-B beta overexpression.
Conclusions:
- SH2-B beta is a novel binding partner for FGFR3.
- SH2-B beta mediates FGFR3 signal transduction, influencing Stat5 activation.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

